MRI Measure May ID Men at Risk for Postradiation Genitourinary Toxicity
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 1, 2023 -- Longer prostatic urethral length measured on prostate magnetic resonance imaging (MRI) is independently associated with a higher risk for developing late genitourinary (GU) toxicity after radiation therapy (RT) for prostate cancer, according to a study published online Oct. 17 in Academic Radiology.
Joseph Lee, M.D., Ph.D., from the Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, and colleagues evaluated pretreatment prostate quantitative MRI measurements and clinical characteristics in predicting GU toxicity after RT for prostate cancer. The analysis included 361 men (June 2016 to February 2023).
The researchers found that 14.4 percent of men experienced grade ≥2 acute toxicity. Brachytherapy (odds ratio, 2.9) was associated with higher odds of acute GU toxicity, while longer membranous urethral length (odds ratio, 0.41) was associated with decreased odds. Median follow-up for late toxicity was 15.0 months with approximately 88.7 percent of patients free of toxicity at one year and 72.0 percent free at three years. An increased risk for late GU toxicity was associated with longer prostatic urethral length (hazard ratio, 1.6), particularly urinary frequency/urgency symptoms (hazard ratio, 1.7).
"This pretreatment metric may be potentially valuable in risk-stratification models for quality of life following prostate RT," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer
FRIDAY, June 28, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in Practical Radiation Oncology...
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.